Table 2.
Comparison of cancer-related gene expression between groups
| a accession No. | Gene symbol | Gene description | A versus B | A versus C | B versus C | |
|---|---|---|---|---|---|---|
| NM 006875 | PIM2 | Pim2 proto-oncogene, serine/Threonine kinase | Ratio | 3.22024 | 3.17383 | 0.98559 |
|
| ||||||
| p value | 0.01640 | 0.00345 | 0.78877 | |||
|
| ||||||
| NM_001080547 | SPI1 | Spi-1 proto-oncogene | Ratio | 1.51520 | 1.77061 | 1.16856 |
|
| ||||||
| p value | 0.00528 | 0.00128 | 0.26196 | |||
|
| ||||||
| NM_000546 | TP53 | Tumor protein p53 | Ratio | 1.00483 | 1.02602 | 1.02109 |
|
| ||||||
| p value | 0.92081 | 0.96759 | 0.91508 | |||
|
| ||||||
| NM_000038 | APC | Adenomatous polyposis coli | Ratio | 0.90633 | 0.95005 | 1.04824 |
|
| ||||||
| p value | 0.43101 | 0.75160 | 0.67150 | |||
A, pediatric patients with active UC; B, pediatric patients with UC in remission; C, pediatric patients with irritable bowel syndrome (control). UC, ulcerative colitis.